🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to document the immunological response to the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362336
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
Primary Objective: * To demonstrate that the immune response of the DTaP-I...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00831311
Treatments Being Tested
The purpose of this study is to evaluate the long term immunogenicity produ...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01105559
To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00313911
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01983540
Primary Objective: To describe the persistence of Hep B antibodies (Ab) at...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02610348